Pain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY ER®
Mar 19, 2018 11:00 am UTC| Business
AUSTIN, Texas, March 19, 2018 -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a drug development company, announced today that the U.S. Food and Drug Administration (FDA) will hold an Advisory Committee Meeting to discuss the...
Mar 19, 2018 11:00 am UTC| Business
DURHAM, N.C., March 19, 2018 -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced data from AdVance, the first large, multi-center study of...
Mar 19, 2018 11:00 am UTC| Business
CARMIEL, Israel, March 19, 2018 -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins...
Mar 19, 2018 11:00 am UTC| Business
Company to host webcast and conference call on Tuesday, March 20, 2018 at 8 am ET Management to discuss recent data and progress on development plans WALTHAM, Mass., March 19, 2018 -- Eloxx Pharmaceuticals, Inc....
M2 Compliance® to Sponsor the 28th Annual Oppenheimer Healthcare Conference
Mar 19, 2018 11:00 am UTC| Business
Los Angeles, CA, March 19, 2018 -- M2 Compliance® ("M2"), www.m2compliance.com, a world-leading filing agent registered with the Securities and Exchange Commission and full-service provider of EDGAR, XBRL, Inline XBRL...
Stifel Completes Acquisition of Ziegler Wealth Management
Mar 19, 2018 11:00 am UTC| Business
ST. LOUIS, March 19, 2018 -- Stifel Financial Corp. (NYSE:SF) today announced that it has completed the acquisition of Ziegler Wealth Management. “We are excited to welcome the team from Ziegler to our wealth...
First Majestic Renews Share Repurchase Program
Mar 19, 2018 11:00 am UTC| Business
VANCOUVER, British Columbia, March 19, 2018 -- First Majestic Silver Corp. (“First Majestic” or the “Company”) announces that its board of directors has approved the extension of its share repurchase program (the “Share...